Target Prediction of Xinyi San for Nasal Polyposis Based on Network Pharmacology
Pharmacology & Pharmacy · 2022 · 13 (02) · 69-80
DOI: 10.4236/pp.2022.132005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology & Pharmacy, 2022. Verfasst von Lingdi Wang und 1 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To analyze the potential mechanism of Xinyi San in treating nasal polyposis through network pharmacology.
Methods
We Screened the active components and targets of Xinyi San by TCMSP database, and disease targets through GeneCards database. We constructed “disease-single drug-component-target” network through software Cytoscape 3.7.2 and constructed PPI network through STRING database. GO function and KEGG pathway enrichment were analyzed to predict its mechanism.
Results
We got 162 components, 69 therapeutic targets, 88 GO items and 135 pathways. The main pathways include Lipid and atherosclerosis, Chemical carcinogenesis-receptor activation, Kaposi sarcoma-associated herpesvirus infection, Hepatitis B, Human cytomegalovirus infection, etc.
Conclusion
This study preliminarily revealed the active components, targets and pathways of Xinyi San in treating nasal polyposis.
Zitieren
APA
Wang, L., & Wang, Y. (2022). Target Prediction of Xinyi San for Nasal Polyposis Based on Network Pharmacology. Pharmacology & Pharmacy, 13(02), 69-80. https://doi.org/10.4236/pp.2022.132005
Vancouver
Wang L, Wang Y. Target Prediction of Xinyi San for Nasal Polyposis Based on Network Pharmacology. Pharmacology & Pharmacy. 2022;13(02):69-80. doi:10.4236/pp.2022.132005
BibTeX
@article{Wang2022,
author = {Wang, Lingdi and Wang, Ying},
title = {Target Prediction of Xinyi San for Nasal Polyposis Based on Network Pharmacology},
journal = {Pharmacology & Pharmacy},
year = {2022},
volume = {13},
number = {02},
pages = {69--80},
doi = {10.4236/pp.2022.132005}
}
EUVIMED